Snapshots International | 12 pages | Novembre 2006 | Anglais
Snapdata's Snapshots UK Pharmaceuticals 2006 provides 2005 year-end market size data, with 2006 estimates, 4 years of historical data and five-year forecasts. The Snapshots report gives an instant ...
IntroductionOsteoarthritis (OA) is characterized by the progressive destruction of articular joints and is a major cause of pain in Western populations. Osteoarthritis is the most common form of a ...
The purpose of this report is to describe the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing. This study examines clinical measurement devices an ...
Increasingly the large pharmaceutical companies are pumping money and ambition into the DNA/RNA therapy market. Whether its through forming collaboration/licensing agreements, or acquiring smaller ...
The Latin American Market Outlook to 2010 is a new management report which provides comprehensive coverage of the major cardiovascular markets in the Latin American region. This report provides det ...
Global Industry Analyst | 285 pages | Août 2006 | Anglais
This report analyzes the worldwide markets for Cholesterol & Other Cardiovascular Testing in Millions of Units. The specific product segments analyzed are Lipid Panel Test/Complete Lipid Profile, T ...
IntroductionTherapeutic vaccines have faced numerous setbacks in recent years. The only three vaccines to reach the market have had insignificant sales, while the pipeline has seen numerous high-pr ...
Global Industry Analyst | 568 pages | Avril 2008 | Anglais
This report analyzes the worldwide markets for Cardiovascular Catheters and Systems in Millions of US$. The major product segments analyzed are Diagnostic Catheters (Angiography Catheters, & Electr ...
IntroductionThis company analysis examines the current position and future outlook for Bayer in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pip ...